Million$ for CEO$ of Drug Companie$ | Arthritis Information

As consumers dig into their pockets to pay for increasing prescription drug prices, CEOs of drug and biotech companies are stuffing their pockets.

CEO pay is currently 364 times that of the average worker's pay. Top US CEOs are paid 200 times more than any other leaders in our society. US CEOs are paid 3 times as much CEOs of large companies in Europe.

Miles White, CEO of Abbott Laboratories, maker of Humira, was paid .76 million in 2007, averaged .47 million over 5 years and owns .5 million in company stock. To see compensation for CEOs Schering-Plough (remicade); Wyeth/Amgen (enbrel) and 15 other CEOs of drug and biotech companies on the Fortune 500 list see link below.

CEOs deserve reasonable and fair compensation, but is current pay excessive? Is it fair to shareholders, the company and employees, and to consumers, who are struggling with increasing health care and drug costs?

http://www.forbes.com/lists/2008/12/lead_bestbosses08_CEO-Compensation-Drugs-Biotechnology_9Rank.html

Article on "2007 Trends in CEO Pay:"

http://www.aflcio.org/corporatewatch/paywatch/pay/index.cfm

I'd like to know the CEO pay for Triaxx if at all possible. Got any leads?

Pip

pip..check out the annual report. if they are a publically traded company it will be in therWhat is Triaxx? If its a Fortune 500 business you could check www.forbes.com. or some financial magazine, like money magazine. Sorry, I really don't know . . .